Provexis PLC Grant of Share Options (0256M)
11 Septiembre 2019 - 10:02AM
UK Regulatory
TIDMPXS
RNS Number : 0256M
Provexis PLC
11 September 2019
11 September 2019
Provexis plc
("Provexis" or the "Company")
Grant of Share Options
Provexis, the business that develops, licenses and sells the
proprietary, scientifically-proven Fruitflow(R) heart-health
functional food ingredient, announces that it has today awarded a
total of 62,500,000 options ('Options') over ordinary shares of 0.1
pence each in the Company ('Ordinary Shares') under the Provexis
2005 share option scheme to certain directors and scientific, sales
and marketing consultants to the Company.
These Options will have an exercise price of 0.30 pence, being
the closing mid-market price on 10 September 2019, and they are
subject to performance criteria (including Ordinary Share price
appreciation). The Options are exercisable, subject to vesting,
between 1 April 2022 and 10 years from the date of grant.
A total of 58,000,000 Options have been awarded to the following
directors:
Director No. of options Existing Total no. Total Options
granted no. of of options as a percentage
options over Ordinary of the Company's
Shares ('Total issued share
Options') capital
Dawson Buck - Chairman 8,000,000 17,000,000 25,000,000 1.26
--------------- ----------- ---------------- ------------------
Ian Ford - CEO &
CFO 25,000,000 25,000,000 50,000,000 2.52
--------------- ----------- ---------------- ------------------
Niamh O'Kennedy -
CSO 25,000,000 13,000,000 38,000,000 1.92
--------------- ----------- ---------------- ------------------
Following the issue of the new Options, the total number of
Ordinary Shares under option which could be issued if all of the
performance criteria are met is 193,500,000 Ordinary Shares,
representing 9.8 per cent. of the Company's issued share
capital.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them are set out below pursuant to the EU Market
Abuse regulation.
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Dawson Buck - Chairman
Ian Ford - CEO & CFO
Niamh O'Kennedy - CSO
-------------------------- ----------------------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------
a) Position/status See 1 a) above
-------------------------- ----------------------------------------------------------
b) Initial notification Initial notification
/
Amendment
-------------------------- ----------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------------
a) Name PROVEXIS PLC
-------------------------- ----------------------------------------------------------
b) LEI 21380042E3Y3N9VZ6N48
-------------------------- ----------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
--------------------------------------------------------------------------------------
a) Description of the Ordinary Shares of 0.1p each
financial instrument,
type of
instrument
ISIN: GB00B0923P27
Identification code
-------------------------- ----------------------------------------------------------
b) Nature of the transaction Grant of options over ordinary shares
-------------------------- ----------------------------------------------------------
c) Price(s) and volume(s) Director/PDMR Price(s) Volume(s)
Dawson Buck - Chairman 0.30p per share 8,000,000
----------------- -----------
Ian Ford - CEO &
CFO 0.30p per share 25,000,000
----------------- -----------
Niamh O'Kennedy -
CSO 0.30p per share 25,000,000
----------------- -----------
-------------------------- ----------------------------------------------------------
d) Aggregated information Price(s) Volume(s)
- Aggregated volume 0.30p per share 58,000,000
- Price -----------
-------------------------- ----------------------------------------------------------
e) Date of the transaction 11 September 2019
-------------------------- ----------------------------------------------------------
f) Place of the transaction Outside a trading venue
-------------------------- ----------------------------------------------------------
For further information please contact:
Provexis plc Tel: 07490 391888
Dawson Buck, Chairman enquiries@provexis.com
Ian Ford, CEO & CFO
Allenby Capital Limited Tel: 020 3328 5656
Nick Naylor / Liz Kirchner
Notes for editors
About Provexis plc
AIM-listed Provexis is focused on the development, licensing and
sales of its proprietary, scientifically-proven Fruitflow(R)
heart-health functional food ingredient.
Provexis was founded in 1999 and is headquartered in Reading,
Berkshire.
Provexis shares are traded on the AIM market of the London Stock
Exchange under the ticker symbol PXS.
For further information, please visit www.provexis.com and
www.fruitflowplus.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHEFLFFKKFBBBB
(END) Dow Jones Newswires
September 11, 2019 11:02 ET (15:02 GMT)
Provexis (LSE:PXS)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Provexis (LSE:PXS)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024